BioCardia, Inc.: Form 10-Q for the period ended Sep 30, 2014
Filed with the SEC on Nov 6, 2014 and accepted by EDGAR at Nov 6, 2014, 10:48 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Operating income | 3 months2014-07-01 to 2014-09-30 | $42.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2014-01-01 to 2014-09-30 | $170.0k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2014-07-01 to 2014-09-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2014-01-01 to 2014-09-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-07-01 to 2014-09-30 | $43.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months2014-01-01 to 2014-09-30 | $173.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-07-01 to 2014-09-30 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2014-01-01 to 2014-09-30 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted shares (weighted) | 3 months2014-07-01 to 2014-09-30 | 230,293,141 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2014-01-01 to 2014-09-30 | 230,293,141 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2014-01-01 to 2014-09-30 | $161.0k | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Cash and equivalents | At period end2014-09-30 | $13.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2014-09-30 | $13.5m | us-gaap:Assets |
| Total liabilities | At period end2014-09-30 | $5.0k | us-gaap:Liabilities |
| Shareholders' equity | At period end2014-09-30 | $13.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001136261-14-000471. Last ingested by Listed: Nov 13, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.